Britta K. Stordal

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Inhibition of Autophagy Reveals ATR Protein Kinase as a Key Mediator of Cisplatin Sensitivity in Osteosarcoma.

Inhibition of Autophagy Reveals ATR Protein Kinase as a Key Mediator of Cisplatin Sensitivity in Osteosarcoma.

Journal: Cancer medicine

Published: June 19, 2025

Nuclear destabilisation - a possible genesis of cancer?

Nuclear destabilisation - a possible genesis of cancer?

Journal: Biological reviews of the Cambridge Philosophical Society

Published: July 19, 2024

Breast cancer risk and prevention in 2024: An overview from the Breast Cancer UK - Breast Cancer Prevention Conference.

Breast cancer risk and prevention in 2024: An overview from the Breast Cancer UK - Breast Cancer Prevention Conference.

Journal: Cancer medicine

Published: May 01, 2024

The efficacy of gemcitabine and docetaxel chemotherapy for the treatment of relapsed and refractory osteosarcoma: A systematic review and pre-clinical study.

The efficacy of gemcitabine and docetaxel chemotherapy for the treatment of relapsed and refractory osteosarcoma: A systematic review and pre-clinical study.

Journal: Cancer medicine

Published: January 12, 2024

Chromosomal copy number and mutational status are required to authenticate ovarian cancer cell lines as appropriate cell models.

Chromosomal copy number and mutational status are required to authenticate ovarian cancer cell lines as appropriate cell models.

Journal: Molecular biology reports

Published: January 09, 2024

Awareness of ovarian cancer symptoms and risk factors in a young ethnically diverse British population.

Awareness of ovarian cancer symptoms and risk factors in a young ethnically diverse British population.

Journal: Cancer medicine

Published: September 29, 2022

Breastfeeding reduces the risk of breast cancer: A call for action in high-income countries with low rates of breastfeeding.

Breastfeeding reduces the risk of breast cancer: A call for action in high-income countries with low rates of breastfeeding.

Journal: Cancer medicine

Published: August 10, 2022

Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.

Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.

Journal: The Cochrane database of systematic reviews

Published: July 22, 2022

Establishment and Characterization of Single and Triple-Agent Resistant Osteosarcoma Cell Lines.

Establishment and Characterization of Single and Triple-Agent Resistant Osteosarcoma Cell Lines.

Journal: Advanced biology

Published: July 11, 2022

The EMT-activator ZEB1 is unrelated to platinum drug resistance in ovarian cancer but is predictive of survival.

The EMT-activator ZEB1 is unrelated to platinum drug resistance in ovarian cancer but is predictive of survival.

Journal: Human cell

Published: April 19, 2022

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer.

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer.

Journal: Obstetrics & gynecology science

Published: February 04, 2020

BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis.

BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis.

Journal: Journal of the National Cancer Institute

Published: February 02, 2020

Showing 1-12 of 23

Last Updated: 09/26/2026